Data |
Ora |
Fonte |
Titolo |
11/6/2024 | 20:32 | EDGAR2 | Form 4 - Statement of changes in beneficial ownership of.. |
10/6/2024 | 22:22 | EDGAR2 | Form 144 - Report of proposed sale of securities |
29/5/2024 | 18:20 | EDGAR2 | Form 4 - Statement of changes in beneficial ownership of.. |
28/5/2024 | 15:43 | EDGAR2 | Form 144 - Report of proposed sale of securities |
24/5/2024 | 16:58 | EDGAR2 | Form 4 - Statement of changes in beneficial ownership of.. |
23/5/2024 | 16:07 | EDGAR2 | Form 144 - Report of proposed sale of securities |
22/5/2024 | 17:34 | EDGAR2 | Form 4 - Statement of changes in beneficial ownership of.. |
21/5/2024 | 20:48 | EDGAR2 | Form 4 - Statement of changes in beneficial ownership of.. |
21/5/2024 | 19:43 | EDGAR2 | Form 144 - Report of proposed sale of securities |
21/5/2024 | 15:00 | BW | Premier’s PINC AI™ and Fortune Name the Nation’s 15 Top.. |
20/5/2024 | 16:31 | EDGAR2 | Form 144 - Report of proposed sale of securities |
16/5/2024 | 21:12 | EDGAR2 | Form 4 - Statement of changes in beneficial ownership of.. |
15/5/2024 | 21:36 | EDGAR2 | Form 144 - Report of proposed sale of securities |
09/5/2024 | 15:00 | BW | Premier, Inc. to Participate in BofA Securities Healthcare.. |
08/5/2024 | 22:01 | EDGAR2 | Form 8-K - Current report |
08/5/2024 | 14:00 | BW | Premier, Inc. Announces Cross-Industry Initiative to Improve.. |
07/5/2024 | 23:16 | EDGAR2 | Form 10-Q - Quarterly report [Sections 13 or 15(d)] |
07/5/2024 | 12:30 | BW | Premier, Inc. Reports Fiscal-Year 2024 Third-Quarter Results |
26/4/2024 | 14:30 | BW | Premier, Inc. Declares Quarterly Cash Dividend |
16/4/2024 | 20:43 | BW | Premier’s PINC AI™ and Fortune Name the Nation’s 100 Top.. |
16/4/2024 | 14:15 | BW | Premier, Inc. to Report Fiscal 2024 Third-Quarter Results.. |
05/3/2024 | 14:30 | BW | Premier, Inc. to Participate in Barclays Global Healthcare.. |
15/2/2024 | 15:10 | BW | PINC AI™ and Fortune Name the Nation’s 50 Top Cardiovascular.. |
13/2/2024 | 14:30 | BW | Premier, Inc.’s PINC AI™ Applied Sciences and Datavant.. |
07/2/2024 | 22:01 | EDGAR2 | Form 8-K - Current report |
06/2/2024 | 22:12 | EDGAR2 | Form 10-Q - Quarterly report [Sections 13 or 15(d)] |
05/2/2024 | 22:30 | BW | Premier, Inc. Completes Strategic Review Process |
26/1/2024 | 12:30 | EDGAR2 | Form 8-K - Current report |
25/1/2024 | 22:15 | BW | Premier, Inc. Declares Quarterly Cash Dividend |
24/1/2024 | 15:15 | PRNUS | LANGaware Forges Transformative Collaboration with Premier,.. |
16/1/2024 | 22:15 | BW | Premier, Inc. to Report Fiscal 2024 Second-Quarter Results.. |
09/1/2024 | 20:00 | EDGAR2 | Form 8-K - Current report |
04/1/2024 | 14:15 | BW | Premier, Inc. to Participate in J.P. Morgan Healthcare.. |
12/12/2023 | 14:00 | BW | Premier, Inc.’s PINC AI™ Applied Sciences (PAS) and TFS.. |
05/12/2023 | 23:25 | EDGAR2 | Form 4 - Statement of changes in beneficial ownership of.. |
05/12/2023 | 23:23 | EDGAR2 | Form 4 - Statement of changes in beneficial ownership of.. |
05/12/2023 | 23:11 | EDGAR2 | Form 4 - Statement of changes in beneficial ownership of.. |
05/12/2023 | 23:06 | EDGAR2 | Form 4 - Statement of changes in beneficial ownership of.. |
05/12/2023 | 15:10 | BW | PINC AI™ and Fortune Name the Nation’s 15 Top Health.. |
04/12/2023 | 13:00 | EDGAR2 | Form 8-K - Current report |
01/12/2023 | 22:02 | EDGAR2 | Form S-8 - Securities to be offered to employees in employee.. |
21/11/2023 | 14:30 | BW | Premier, Inc. to Participate in Piper Sandler Healthcare.. |
15/11/2023 | 14:00 | BW | Tufts Medicine Selects Premier, Inc. as Strategic Partner to.. |
13/11/2023 | 16:58 | EDGAR2 | Form 4 - Statement of changes in beneficial ownership of.. |
09/11/2023 | 23:35 | EDGAR2 | Form 144 - Report of proposed sale of securities |
08/11/2023 | 22:01 | EDGAR2 | Form 8-K - Current report |
07/11/2023 | 22:15 | EDGAR2 | Form 10-Q - Quarterly report [Sections 13 or 15(d)] |
07/11/2023 | 12:30 | BW | Premier, Inc. Reports Fiscal-Year 2024 First-Quarter Results |
26/10/2023 | 22:15 | BW | Premier, Inc. Declares Quarterly Cash Dividend |
18/10/2023 | 22:05 | EDGAR2 | Form DEF 14A - Other definitive proxy statements |